[Federal Register Volume 85, Number 93 (Wednesday, May 13, 2020)]
[Notices]
[Page 28645]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10156]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Biodefense Science Board
AGENCY: Office of the Assistant Secretary for Preparedness and Response
(ASPR), Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Biodefense Science Board (NBSB) is authorized
under Section 319M of the Public PHS Act, as added by Section 402 of
the Pandemic and All-Hazards Preparedness Act of 2006 and amended by
Section 404 of the Pandemic and All-Hazards Preparedness
Reauthorization Act. The Board is governed by the Federal Advisory
Committee, which sets forth standards for the formation and use of
advisory committees. The NBSB provides expert advice and guidance on
scientific, technical, and other matters of special interest to the
Department regarding current and future chemical, biological, nuclear,
and radiological agents, whether naturally occurring, accidental, or
deliberate.
Background: The May 13, 2020, NBSB public teleconference is
dedicated to the discussion of recommendations on two topics: (1) NBSB
Rapid medical countermeasures (MCM) for Disease X and (2) Integrating
Clinical Disaster Response Training with Community and State Based
Emergency Planning. We will post modifications to the agenda and/or
topics on the NBSB meeting website, which is located at https://www.phe.gov/nbsb.
Availability of Materials: We will post all teleconference
materials prior to the teleconference on May 13, 2020, on the website
located at https://www.phe.gov/nbsb.
Procedures for Providing Public Input: Members of the public may
attend the public teleconference via a toll-free call-in phone number,
which is available on the NBSB website at https://www.phe.gov/nbsb.
FOR FURTHER INFORMATION CONTACT: Maxine Kellman, DVM, Ph.D., PMP,
Alternate Designated Federal Official for National Advisory Committees,
Washington, DC, Office (202) 260-0447 or email [email protected].
SUPPLEMENTARY INFORMATION: We encourage members of the public to
provide written comments that are relevant to the NBSB public
teleconference prior to May 13, 2020. Send written comments by email to
[email protected] with ``NBSB Public Comment'' in the subject line. The NBSB
Chair will respond to comments received by May 13, 2020, via email and/
or during the public teleconference. Due to the Coronavirus Disease
2019 (COVID-19) pandemic response, there was an administrative delay
with the posting of this Federal Register notice to announce the
National Biodefense Science Board (NBSB) May 13, 2020 Public
Teleconference.
Robert P. Kadlec,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2020-10156 Filed 5-12-20; 8:45 am]
BILLING CODE 4150-37-P